Bharat Biotech enters into partnership with Biofabri for TB vaccine
The new TB vaccine, 'MTBVAC', is being manufactured and developed by Biofabri, in close collaboration with the University of Zaragoza, IAVI and the Tuberculosis Vaccine Initiative (TBVI).
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: AIDS Vaccine | Biotechnology | Partnerships | Pharmaceuticals | Tuberculosis | Tuberculosis (BCG) Vaccine | Vaccines